"Hirudin Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Use of HIRUDINS as an anticoagulant in the treatment of cardiological and hematological disorders.
Descriptor ID |
D024764
|
MeSH Number(s) |
E02.319.913.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hirudin Therapy".
Below are MeSH descriptors whose meaning is more specific than "Hirudin Therapy".
This graph shows the total number of publications written about "Hirudin Therapy" by people in this website by year, and whether "Hirudin Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 1 | 0 | 1 |
2004 | 0 | 2 | 2 |
2010 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hirudin Therapy" by people in Profiles.
-
Synergistic protection in lung ischemia-reperfusion injury with calcineurin and thrombin inhibition. Ann Thorac Surg. 2010 Jun; 89(6):1766-71.
-
Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUIT. Am Heart J. 2004 Jul; 148(1):62-71.
-
Thrombin, a mediator of neurotoxicity and memory impairment. Neurobiol Aging. 2004 Jul; 25(6):783-93.
-
Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET). Am Heart J. 2002 May; 143(5):847-53.